Marathon Patent Group (MARA) vs. Sharps Compliance Corp (NASDAQ:SMED) Head to Head Analysis

Sharps Compliance Corp (NASDAQ: SMED) and Marathon Patent Group (NASDAQ:MARA) are both small-cap industrial products companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, profitabiliy, earnings, dividends and valuation.

Volatility and Risk

Sharps Compliance Corp has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500. Comparatively, Marathon Patent Group has a beta of 0.46, indicating that its stock price is 54% less volatile than the S&P 500.

Profitability

This table compares Sharps Compliance Corp and Marathon Patent Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Sharps Compliance Corp -4.47% -3.66% -2.64%
Marathon Patent Group -81.91% -1,139.06% -92.34%

Analyst Ratings

This is a breakdown of recent ratings and price targets for Sharps Compliance Corp and Marathon Patent Group, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sharps Compliance Corp 0 1 0 0 2.00
Marathon Patent Group 0 0 1 0 3.00

Sharps Compliance Corp currently has a consensus target price of $6.00, indicating a potential upside of 9.09%. Marathon Patent Group has a consensus target price of $3.00, indicating a potential upside of 1,088.59%. Given Marathon Patent Group’s stronger consensus rating and higher possible upside, analysts clearly believe Marathon Patent Group is more favorable than Sharps Compliance Corp.

Valuation & Earnings

This table compares Sharps Compliance Corp and Marathon Patent Group’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Sharps Compliance Corp $36.70 million 2.40 $497,999.00 ($0.10) -54.99
Marathon Patent Group $34.65 million 0.17 $8.58 million ($1.86) -0.14

Marathon Patent Group has higher revenue, but lower earnings than Sharps Compliance Corp. Sharps Compliance Corp is trading at a lower price-to-earnings ratio than Marathon Patent Group, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

26.1% of Sharps Compliance Corp shares are owned by institutional investors. Comparatively, 14.0% of Marathon Patent Group shares are owned by institutional investors. 20.3% of Sharps Compliance Corp shares are owned by insiders. Comparatively, 19.8% of Marathon Patent Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Sharps Compliance Corp beats Marathon Patent Group on 9 of the 13 factors compared between the two stocks.

Sharps Compliance Corp Company Profile

Sharps Compliance Corp. is a provider of waste management services, including medical, pharmaceutical and hazardous. The Company’s solutions include Sharps Recovery System, TakeAway Medication Recovery System, MedSafe, Route-Based Pickup Service, TakeAway Recycle System, ComplianceTRAC, Universal Waste Shipback Systems and Other Solutions. The Company’s solutions facilitate the collection, containment, transportation and treatment of various types of healthcare-related materials, including hypodermic needles, lancets and other devices or objects used to puncture or lacerate the skin, or sharps, hazardous waste and unused consumer dispensed medications and over-the-counter drugs. It assists its customers in determining which of its solution offerings fit for the collection, containment, return transportation and treatment of medical waste, used healthcare materials, pharmaceutical waste, hazardous waste and unused dispensed medications. It provides tracking and reporting tools.

Marathon Patent Group Company Profile

Marathon Patent Group Inc. (MARA) is engaged in acquiring patents and patent rights from owners or other ventures. The Company monetizes its portfolio of patents and patent rights by entering into license discussions. The Company owns around 378 United States and foreign patents, and patent rights across a range of technologies and markets. The Company owns around 22 patent applications across a range of technologies and markets.

What are top analysts saying about Sharps Compliance Corp? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Sharps Compliance Corp and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit